期刊文献+

基于价值流程图的缺血性脑卒中患者静脉溶栓院内延迟现状分析 被引量:39

The hospital delay analysis of intravenous thrombolysis process among ischemic stroke patients based on value stream mapping
在线阅读 下载PDF
导出
摘要 目的:系统分析缺血性脑卒中患者静脉溶栓院内价值流程图,为流程的优化提供依据。方法:采用目的抽样法,对31例缺血性脑卒中静脉溶栓患者进行全程跟踪调查,绘制价值流程图并分析院内各环节的活动。结果:缺血性脑卒中患者静脉溶栓院内总流程时间为81~196min,总工作时间为45~98min,总延误时间为36~98min;结论:缺血性脑卒中患者静脉溶栓院内流程存在较大改进空间,快速的预检分诊、科室间的团队合作、可视化管理、多样化的病情告知方式等是优化缺血性脑卒中患者静脉溶栓院内流程的关键措施。 Objective:To analyze systematically the effect of value stream map of intravenous thrombolysis process among ischemic stroke patients and to provide the basis for process optimization. Methods:Totally 31 ischemic stroke patients with intravenous thrombolysis were recruited by purposive sampling methods and were followed up throughout the whole study. We drawed the value stream map and analyzed the activities in the hospital. Results:The mean time of hospital intravenous thrombolysis among ischemic stroke patients was 81-196 minutes, the process time was 45-98 minutes, the delay time was 36-98 minutes. Conclusion:The intravenous thrombolysis process among ischemic stroke patients has a great improvement space. The key measures to optimize intravenous thrombolysis process were timely and accurate evaluation, the cooperation and communication of each department, visual management, and diverse informed consent form.
出处 《中国护理管理》 CSCD 2015年第5期591-594,共4页 Chinese Nursing Management
基金 2010年国家临床重点专科建设项目
关键词 价值流程图 缺血性脑卒中 静脉溶栓 value stream mapping ischemic stroke intravenous thrombolytic
作者简介 苏林霞,硕士在读 通信作者:杨莘,教授,硕士生导师,主任护师,E—mail:yngxn@163.com
  • 相关文献

参考文献18

  • 1Yang G,Wang Y, Zeng Y, et al.Rapid health transition in China,1990-2010: findings from the Global Burden of Disease Study 2010.Lancet,2013,381(9882): 1987-2015.
  • 2中国急性缺血性脑卒中治疗现状[J].中华神经科杂志,2009,42(4):223-228. 被引量:100
  • 3The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasrninogen activator for acute isehemie stroke. NEngl J Med, 1995,333(24):1581-1587.
  • 4Hacke W, Kaste M,Bluhmki E,et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.N Engl J Med,2008,359(13):1317-1329.
  • 5Gumbinger C,Reuter B,Stock C,et al.Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results fi'om randomized clinical trials.BMJ,2014(348):g3429.
  • 6Jauch EC,Saver JL,Adams HP Jr, et al.American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology.Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Stroke,2013,44(3):870-947.
  • 7Wang YL,Liao XL,Zhao XQ,et al.Using Recombinant Tissue Plasminogen Activator to treat acute ischemic stroke in China:analysis of the results from the Chinese national stroke registry.Stroke,2011, 42(6):1658-1664.
  • 8Fonarow GC,Smith EE,Saver JL,et al.Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke:patient characteristics,hospital factors,and outcomes associated with door-to-needle times within 60 minutes.Circulation,2011,123(7):750- 758.
  • 9Wahlgren N,Ahmed N,Dhvalos A,et al.SITS investigators.Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-1STR):an observational study.Lancet,2008,372(9646): 1303-1309.
  • 10孙娜.精益六西格玛在患者安全流程改造的应用研究.重庆:第三军医大学,2011.

二级参考文献69

共引文献177

同被引文献349

引证文献39

二级引证文献529

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部